Leading British nurse awarded top US healthcare honour

August 01, 2024 09:22 PM AEST | By EIN Presswire
 Leading British nurse awarded top US healthcare honour
Image source: EIN Presswire
LONDON, UNITED KINGDOM, August 1, 2024 /EINPresswire.com/ -- Sciensus is pleased to announce that Professor Sir Jonathan Asbridge, Chief Clinical Officer at Sciensus, has been selected to become a Fellow of the American Academy of Nursing. Induction into the Academy is a significant milestone in a nurse leader’s career in which their accomplishments are honoured by their colleagues within and outside the profession. Fellows are selected based on their contributions and impact to advance the public’s health.

The Academy is a policy organization and an honorific society that recognizes nursing's most accomplished leaders in policy, research, practice, administration, and academia to advance equitable solutions to the most complex health care challenges. Academy Fellows hold a wide variety of influential roles in health care in the United States and abroad. Induction into the Fellowship represents more than recognition of one's accomplishments within the nursing profession. Fellows contribute their collective expertise to the Academy, engaging with health leaders nationally and globally to improve health and achieve health equity by impacting policy through nursing leadership, innovation, and science.

At Sciensus, Jonathan ensures that we deliver excellent service for patients, the NHS and our pharmaceutical partners. Prior to joining Sciensus, Jonathan served as Chief Nurse of the Oxford University and Cambridge University Teaching Hospitals He was formerly President of the UK Nursing and Midwifery Council, Chief Nurse at the Oxford and Cambridge teaching hospitals, and Chief Executive and Chief Nurse of Bart’s and The London NHS Trust. In addition to his role at Sciensus, Jonathan is also President and Chairman of Council of the ESPCH.

Darryn Gibson, Chief Executive Officer, Sciensus: “We are delighted that Jonathan has been chosen to become a Fellow of the American Academy of Nursing. Jonathan has dedicated his career to nursing and it is wonderful to see his efforts acknowledged by an organisation which represents nursing’s most accomplished leaders. At Sciensus, we are committed to continuously improving our patients’ experience, and that’s why it’s important we draw from the best expertise and knowledge in the sector.”

Prof Sir Jonathan Asbridge, Chief Clinical Officer, Sciensus: “I am honoured to have been recognised by the American Academy of Nursing. I look forward to actively participating in the organisation and supporting the society.”

The newest Fellows, selected from a competitive pool of applicants, represent 37 states, the District of Columbia, Guam, and 14 countries. Their unique expertise and expansive body of knowledge will soon bolster the collective impact of over 3,000 Academy Fellows to achieve the Academy’s vision of healthy lives for all people.

Jonathan Asbridge and the 2024 inductees will be recognized for their substantial, sustained, and significant contributions to health and health care at the Academy’s annual Health Policy Conference, taking place on October 31 – November 2, 2024 in Washington, DC during the Induction Ceremony on the evening of November 2nd. After the ceremony, the new inductees can use their FAAN (Fellow of the American Academy of Nursing) credential, the most prestigious recognition in nursing.

Kasia Banas
Teneo
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.